• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 2.84% Nasdaq Down 2.94%

    Merrimack Pharmaceuticals, Inc. (MACK)

    -NasdaqGM
    9.53 Down 0.56(5.55%) 4:00PM EDT
    |After Hours : 9.53 0.00 (0.00%) 5:10PM EDT
    Add to Portfolio
    Prev Close:10.09
    Open:9.86
    Bid:9.00 x 6200
    Ask:10.15 x 1000
    1y Target Est:15.17
    Beta:1.1137
    Earnings Date:Nov 9 - Nov 13 (Est.)
    Day's Range:9.46 - 10.00
    52wk Range:6.38 - 13.84
    Volume:1,103,146
    Avg Vol (3m):1,325,780
    Market Cap:1.06B
    P/E (ttm):N/A
    EPS (ttm):-0.89
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    MACKDown 5.55%1.06B
    IMMUDown 1.85%200.61M
    THLDDown 2.14%293.19M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):9.92
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.12
    Quarterly EPS Est (Sep-15) :-0.38
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):-1.66

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer primarily in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback